logo logo-mobile

  • Home
  • Product
    • FDF
    • API
  • About Us
    • Profiles
    • Video
    • Honor
  • News
  • Contact Us

中/EN

logo logo-mobile

  • Home
  • Product
    • FDF
    • API
  • About Us
    • Profiles
    • Video
    • Honor
  • News
  • Contact Us
  • 硝酸甘油注射液
    WANHAN PHARMACEUTICAL COMPANY: Nitroglycerin Injection has been successfully approved.
  • 依帕司他喜报
    WANHAN PHARMACEUTICAL COMPANY丨API Epalrestat has been successfully authorized.
  • 布美他尼喜报
    WANHAN PHARMACEUTICAL COMPANY丨API Bumetanide has been successfully authorized.
  • 参会邀请
    Wanhan Pharmaceutical Company 丨 Visit us at Booth 711 International Exhibition of Pharmaceuticals, Engineering and Biotechnology
  • 氢溴酸伏硫西汀片
    WANHAN PHARMACEUTICAL COMPANY: Vortioxetine Hydrobromide Tablets has been successfully approved.
  • 西鼎会邀请海报_画板 1
    WANHAN PHARMACEUTICAL COMPANY: Join us at the Xiding Conference in Huzhou, March 14-18!
  • 春节放假通知
    Holiday Notice | Wanhan Pharmaceutical Company sends warm greetings and best wishes for a Happy Chinese New Year!
  • 重酒石酸去甲肾上腺素喜报
    Congratulations to the approval of API Norepinephrine Bitartrate!
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7

Contact Us

Foreign Trade (API, FDF)

 

Mob:

+86 139 - 2498 - 2439(WeChat&WhatsApp)

+86 199 - 2800 - 9162(WhatsApp)

+86 199 - 6631 - 1970(WhatsApp)

 

E-mail:

Foreign-Trade@whpt.com.cn 

Copyright @ 2023: Zhongshan Wanhan Pharmaceutical Co., Ltd.